Galectin Therapeutics
GALT
#8074
Rank
A$0.25 B
Marketcap
$4.12
Share price
1.48%
Change (1 day)
38.09%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.16 B

According to Galectin Therapeutics's latest financial reports the company's total liabilities are A$0.16 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$78.58 M45.73%
2021-12-31A$53.92 M668.53%
2020-12-31A$7.01 M71.75%
2019-12-31A$4.08 M36.58%
2018-12-31A$2.99 M-21.32%
2017-12-31A$3.8 M-27.5%
2016-12-31A$5.24 M180.87%
2015-12-31A$1.86 M-10.1%
2014-12-31A$2.07 M-25.49%
2013-12-31A$2.78 M75.78%
2012-12-31A$1.58 M-26.6%
2011-12-31A$2.16 M-72.64%
2010-12-31A$7.89 M44.03%
2009-12-31A$5.48 M222.78%
2008-12-31A$1.69 M-68.46%
2007-12-31A$5.38 M-33.51%
2006-12-31A$8.09 M329.46%
2005-12-31A$1.88 M45.22%
2004-12-31A$1.29 M155.38%
2003-12-31A$0.5 M-57.03%
2002-12-31A$1.18 M9.68%
2001-12-31A$1.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.27 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.00 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA